Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pancreatic Neoplasms × Protons × Clear all

Phase

Status

Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 2 Meningioma 2 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Resectable Lung Non-Small Cell Carcinoma 1 Pituitary Neoplasms 1 Pancreatic Neoplasms 1 Neurilemmoma 1 Nerve Sheath Neoplasms 1 Ion Beam Radiation Therapy for Tumor Patients 1 Gastroesophageal Junction Adenocarcinoma 1 Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Gemcitabine 51 130-nm albumin-bound paclitaxel 25 Magnetic Resonance Spectroscopy 17 Specimen Handling 16 Albumin-Bound Paclitaxel 15 pembrolizumab 14 Leucovorin 14 Fluorouracil 14 Taxes 13 Oxaliplatin 13 Drug Therapy 13 Irinotecan 11 Cyclophosphamide 11 fludarabine 10 Biopsy 10 Blood Specimen Collection 8 olaparib 6 irinotecan sucrosofate 6 Cetuximab 6 folfirinox 5 dehydroftorafur 5 Radiotherapy 5 Radiosurgery 5 Capecitabine 5 Bevacizumab 5 sintilimab 4 durvalumab 4 balstilimab 4 aldesleukin 4 Surveys and Questionnaires 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04894643 2025-05-08

PARC

EBG MedAustron GmbH

Phase NA Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡